Effect of intensive treatmenton vascular and other complications of diabetes mellitus

The Diabetes Control and Complications Trial Research Group (DCCT), 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med., 329, 977, 10.1056/NEJM199309303291401 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med., 348, 383, 10.1056/NEJMoa021778 2002, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001/jama.287.19.2563 2003, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology ofDiabetes Interventions and Complications (FDIC) study, JAMA, 290, 2159, 10.1001/jama.290.16.2159 Nathan, 2003, Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus, N Engl J Med., 348, 2294, 10.1056/NEJMoa022314 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 Stratton, 2000, Association of glycemia with microvascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetesmellitus: A randomized prospective 6-year study, Diabetes Res Clin Pract., 28, 103, 10.1016/0168-8227(95)01064-K Capes, 2000, Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without dia betes: A systematic overview, Lancet, 355, 773, 10.1016/S0140-6736(99)08415-9 Malmberg, 1997, Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group, BMJ, 314, 1512, 10.1136/bmj.314.7093.1512 Chaudhuri, 2004, Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction, Circulation, 109, 849, 10.1161/01.CIR.0000116762.77804.FC Van den Berghe, 2001, Intensive insulin therapy in the critically ill patients, N Engl J Med., 345, 1359, 10.1056/NEJMoa011300 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a King, 1996, The cellular and molecular mechanisms of diabetic complications, Endocrinol Metab Clin North Am., 25, 255, 10.1016/S0889-8529(05)70324-8 Sheetz, 2002, Molecular understanding of hyperglycemia's adverse effects for diabetic complications, JAMA, 288, 2579, 10.1001/jama.288.20.2579 McFarlane, 2001, Nearnormoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta cell function, Diabet Med., 18, 10, 10.1046/j.1464-5491.2001.00395.x Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med., 346, 393, 10.1056/NEJMoa012512 Ryan, 2003, Look AHEAD (Action for Health in Diabetes): Design and methods for a clinical trial of weight loss for the pre vention of cardiovascular disease intype 2 diabetes, Control Clin Trials., 24, 610, 10.1016/S0197-2456(03)00064-3 Hamdy, 2003, Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome, Diabetes Care, 26, 2119, 10.2337/diacare.26.7.2119 Banerji, 1996, Longterm normoglycemic remission in black newly diagnosed NIDDM subjects, Diabetes, 45, 337, 10.2337/diabetes.45.3.337 Riddle, 2003, The Treat-toTarget Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients, Diabetes Care, 26, 3080, 10.2337/diacare.26.11.3080 Collins, 2003, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A ran domised placebo-controlled trial, Lancet, 361, 2005, 10.1016/S0140-6736(03)13636-7 Heart Outcomes Prevention Evaluation Study Investigators, 2000, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICROHOPE substudy, Lancet, 355, 253, 10.1016/S0140-6736(99)12323-7 Outcome Reduction with Initial Glargine Intervention (ORIGIN). Available at: http://clinicaltrials.gov. Accessed July 14, 2004.